10 Stryker finance leaders
Stryker's CFO, Preston Wells, sits beside finance directors for corporate FP&A, treasury FP&A and capital planning, Flex Financial U.S., Joint Replacement planning, Trauma & Extremities, EMEA and MSNT & Endo, plus a Shanghai-based senior finance director and a former VP of finance for spine. Nine hold current Stryker titles, so the group fits a medical device finance team rethinking how corporate planning and division finance divide the work.
Professionals to explore
Dan Matrisciano
LinkedInExperience: Director, Corporate FP&A · Stryker
$404 per 30-minute call
Dan Matrisciano moved into Director, Corporate FP&A at Stryker in December 2025 from Sr. Finance Manager - Hip Business Unit (2022–2025), where Matrisciano was the senior finance lead for the Hip Business Unit. Other Stryker titles include Finance Manager - Joint Replacement Reporting (2020–2022) and Associate Finance Manager - Neurotechnology, Instruments and Spine Group (2018–2020), a fit for questions on corporate planning built up from business units.
Is this you? Claim your profile and get paid for calls.
Franziska Opitz- de Rooij
LinkedInExperience: Senior Director Finance · Stryker
$505 per 30-minute call
Franziska Opitz- de Rooij's current title is Senior Director Finance at Stryker (since 2025), a role tied to MSNT & Endo. Opitz- de Rooij also held Director Finance NV EMEA (2024–2025), Senior Finance Manager Stryker Neurovascular EMEA (2022–2024) and Senior Manager A2R Commercial & Intercompany (2020–2022) at Stryker, and was Senior Manager Finance & Accounting EMEA at Starbucks (2017–2019).
Is this you? Claim your profile and get paid for calls.
Jacqueline Rivera, CPA
LinkedInExperience: Senior Director, Financial Planning & Analysis · Stryker
$505 per 30-minute call
As Senior Director, Financial Planning & Analysis at Stryker since 2024, Jacqueline Rivera, CPA is a strategic partner for key commercial activities across the Joint Replacement division, keeping plans aligned with organizational strategy. Rivera was Senior Director, Group Finance Controller at Stryker (2022–2024) and Group Controller at Integra LifeSciences (2018–2023), plus Audit Senior Manager at Deloitte (2016–2018).
Is this you? Claim your profile and get paid for calls.
Melissa Conway
LinkedInExperience: Former Senior Director Finance, Trauma & Extremities Division · Stryker
$505 per 30-minute call
Since January 2024, Melissa Conway has been Senior Director Finance, Trauma & Extremities Division at Stryker, after Senior Director Finance, Emergency Care (2020–2024). Conway also held Director Of Finance (2019–2020), Director of Financial Planning and Analysis (2017–2018) and Finance Director- WW Operations and R&TD (2016–2017) at Stryker and cites forecasting, target setting, budgeting and financial modeling.
Is this you? Claim your profile and get paid for calls.
Micah Klaassen
LinkedInExperience: Director of Finance, Treasury FP&A and Capital Planning · Stryker
$438 per 30-minute call
Treasury and capital questions fit Micah Klaassen, Director of Finance, Treasury FP&A and Capital Planning at Stryker since 2025. Klaassen was Director of Finance at Stryker (2022–2025), supporting the Ear Nose & Throat (ENT) business unit of Stryker Instruments, Controller - Global Customer Care at Stryker (2020–2022) and CFO at Inovelli (2019–2020).
Is this you? Claim your profile and get paid for calls.
Patrick Bauer
LinkedInExperience: Senior Finance Director EMEA · Stryker
$505 per 30-minute call
Patrick Bauer is Senior Finance Director EMEA at Stryker (since 2025) and held Senior Finance Director EEMEA (2019–2025), Regional Finance Director GSAP (2015–2019) and Interim Business Unit Director Surgical GSAP (2017–2018) there. Bauer was also Regional Finance Director GER AT CEE at Smith+Nephew (2012–2015) and describes partnering with CEOs and GMs, a fit for regional finance questions across EMEA.
Is this you? Claim your profile and get paid for calls.
Preston Wells
LinkedInExperience: Vice President, Chief Financial Officer · Stryker
$4,039 per 30-minute call
Preston Wells has been Vice President, Chief Financial Officer at Stryker since April 2025, after Vice President, Group Chief Financial Officer Stryker Orthopaedics and Spine (2022–2025). Wells also held Vice President of Investor Relations (2020–2022), Vice President Financial Planning Analysis (2016–2020) and Sr Finance Director (2015–2016) at Stryker, a combination that covers group finance, investor relations and planning.
Is this you? Claim your profile and get paid for calls.
Rachel Krider
LinkedInExperience: Financial Director · Stryker
$336 per 30-minute call
Rachel Krider holds two current Stryker titles, Financial Director since August 2026 and Flex Financial US Controller since 2024, and is responsible for finance, accounting, internal controls and financial reporting for Flex Financial U.S. Krider also held Financial Compliance Manager (2023–2024) and Technical Accounting Manager (2022–2023) at Stryker, which suits questions on controls and technical accounting.
Is this you? Claim your profile and get paid for calls.
Shuoqian (Cecilia) Liang
LinkedInExperience: Sr. Finance Director · Stryker
$471 per 30-minute call
Shuoqian (Cecilia) Liang has been Sr. Finance Director at Stryker since October 2022, based in Shanghai. Liang was Finance Director at Beckman Coulter Diagnostics (2020–2022), Finance Director, APAC at Beckman Coulter Life Sciences (2016–2020) and Commercial Finance Controller at Beckman Coulter Diagnostics (2014–2016), useful for questions on commercial finance in China and APAC.
Is this you? Claim your profile and get paid for calls.
Yiyun Chan
LinkedInExperience: Former Vice President, Finance & Commercial Operations · Stryker
$1,010 per 30-minute call
Yiyun Chan was Vice President, Finance & Commercial Operations at Stryker (2021–2022), directing finance and commercial analytics teams for the core spine implant business. Chan's other Stryker titles were Senior Director, Finance Robotics & Digital Technologies (2018–2021), Finance Director (2016–2018) and Assistant Finance Director (2014–2016), which fits questions on finance for robotics and spine businesses.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
Company-wide planning and investor questions belong with Preston Wells, and Dan Matrisciano and Micah Klaassen cover corporate FP&A and treasury and capital planning. Division economics sit with Jacqueline Rivera (Joint Replacement), Melissa Conway (Trauma & Extremities, earlier Emergency Care) and Yiyun Chan (spine, a role that ended in 2022), while Patrick Bauer, Franziska Opitz- de Rooij and Shuoqian (Cecilia) Liang give the regional view and Rachel Krider covers controls and reporting for Flex Financial U.S.
Questions to take into the conversation
- 01How does a medical device maker set the planning calendar between corporate FP&A and division finance for implants, instruments and capital equipment?
- 02What does a division finance lead track monthly for a business like joint replacement or trauma that differs from what corporate FP&A tracks?
- 03How do regional finance directors in EMEA or China handle pricing and tender economics that vary by country?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.